Nanobiotix S.A. NANO-Product Pipeline Analysis, 2016 Update

Nanobiotix S.A. NANO-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME87155PD
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Nanobiotix S.A. (Nanobiotix) is a nanomedicine company that develops tools for local treatment of cancer. The company is developing product portfolio that consists of three products designed to meet specific clinical needs for different cancers, which include NBTXR3, NBTX IV, and TOPO NBTX. Its NBTXR3 nanoparticles are designed for direct injection into the tumor. Nanobiotix's NBTX-IV nanoparticles are designed for intravenous injection. The company's NBTX-TOPO nanoparticles is a gel to be applied during surgery after removal of the tumor. It also develops other nanomedicine programs such as nanoMag, magnetic particles for the treatment and diagnosis of cancer; and nanoPDT. The company has presence in the US and France. Nanobiotix is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Nanobiotix S.A.

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Nanobiotix S.A. Company Snapshot 5

Nanobiotix S.A. Company Overview 5

Nanobiotix S.A. Pipeline Products and Clinical Trials Overview 6

Nanobiotix S.A.-Pipeline Analysis Overview 8

Key Facts 8

Nanobiotix S.A.-Major Products and Services 9

Nanobiotix S.A. Pipeline Products by Development Stage 10

Nanobiotix S.A. Clinical Trials by Trial Status 12

Nanobiotix S.A. Pipeline Products Overview 14

NanoMag 14

NanoMag Product Overview 14

NanoPDT 15

NanoPDT Product Overview 15

NBTXR3-Head & Neck Cancer 16

NBTXR3-Head & Neck Cancer Product Overview 16

NBTXR3-Liver Cancer 17

NBTXR3-Liver Cancer Product Overview 17

NBTXR3-Soft Tissue Sarcoma 18

NBTXR3-Soft Tissue Sarcoma Product Overview 18

NBTXR3-Soft Tissue Sarcoma Clinical Trial 19

Nanobiotix S.A.-Key Competitors 20

Nanobiotix S.A.-Key Employees 21

Nanobiotix S.A.-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Nanobiotix S.A., Recent Developments 23

Nov 13, 2015: Nanobiotix revenue for Q3 2015 23

Nov 13, 2015: Nanobiotix's Soft Tissue Sarcoma pivotal trial progressing well as planned: already 7 countries and 29 sites opened 23

Aug 27, 2015: Nanobiotix Half Year Results For The Six Months Ended 30 June 2015, In Line With Expectations 24

Apr 14, 2015: Nanobiotix: 2014 Annual Results 26

Feb 19, 2015: Professor Robert Langer joins Nanobiotix as Scientific Advisor 27

Sep 22, 2014: Nanobiotix Expands Operations into the USA as Part of Its International Development Strategy 28

Aug 28, 2014: Nanobiotix Announces Half Year Results for the six months ended 30 June 2014 28

Jul 11, 2014: Nanobiotix revenue for the 2nd quarter of 2014 32

Apr 15, 2014: Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply 32

Apr 11, 2014: Nanobiotix Announces 2013 Annual Results 32

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

Nanobiotix S.A. Pipeline Products by Equipment Type 7

Nanobiotix S.A. Pipeline Products by Development Stage 10

Nanobiotix S.A. Clinical Trials by Trial Status 12

List of Tables

Nanobiotix S.A. Pipeline Products and Clinical Trials Overview 6

Nanobiotix S.A. Pipeline Products by Equipment Type 6

Nanobiotix S.A. Pipeline Products by Indication 7

Nanobiotix S.A. Clinical Trials by Trial Status 7

Nanobiotix S.A., Key Facts 8

Nanobiotix S.A., Major Products and Services 9

Nanobiotix S.A. Number of Pipeline Products by Development Stage 10

Nanobiotix S.A. Pipeline Products Summary by Development Stage 11

Nanobiotix S.A. Clinical Trials by Trial Status 12

Nanobiotix S.A. Clinical Trials Summary 13

NanoMag-Product Status 14

NanoMag-Product Description 14

NanoPDT-Product Status 15

NanoPDT-Product Description 15

NBTXR3-Head & Neck Cancer-Product Status 16

NBTXR3-Head & Neck Cancer-Product Description 16

NBTXR3-Liver Cancer-Product Status 17

NBTXR3-Liver Cancer-Product Description 17

NBTXR3-Soft Tissue Sarcoma-Product Status 18

NBTXR3-Soft Tissue Sarcoma-Product Description 18

NBTXR3-Soft Tissue Sarcoma-Multicenter, Randomized, Open-label Phase II/III Study, to Compare Efficacy of NBTXR3 Implanted as Intratumor Injection and Activated by Radiotherapy versus Radiotherapy Alone in Patients with Locally Advanced Soft Tissue Sarcoma (Extremity and Trunk Wall) 19

NBTXR3-Soft Tissue Sarcoma-PhI Study of NBTXR3 with Intensity Modulated Radiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Oral Cavity or Oropharynx 19

Nanobiotix S.A., Key Employees 21

Nanobiotix S.A., Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Nanobiotix S.A., Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53835
Site License
USD 1,500 INR 72
Corporate User License
USD 2,250 INR 144



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]